<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-23T20:36:07+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>全球首个KRAS靶点药物Sotorasib向EMA提交上市许可申请</title>
    <updated>2020-12-23T16:41:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/aV5b04u_TAsyHkFyEeHCfQ</id>
    <link href="https://mp.weixin.qq.com/s/aV5b04u_TAsyHkFyEeHCfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药械审大湾区分中心成立！与昨天成立的长三角分中心有这些不同</title>
    <updated>2020-12-23T16:41:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/QKExlzy_hLnQ7diSQnNbMw</id>
    <link href="https://mp.weixin.qq.com/s/QKExlzy_hLnQ7diSQnNbMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BV Release | 维立志博LBL-003注射液获美国FDA临床试验许可</title>
    <updated>2020-12-23T16:41:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/4hkOkzBoN8-HIDepMQL19w</id>
    <link href="https://mp.weixin.qq.com/s/4hkOkzBoN8-HIDepMQL19w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>变数横生：uniQure血友病基因疗法临床Ⅲ期遭FDA搁置</title>
    <updated>2020-12-22T12:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/-PRfwy2IVg4NfnCtJ-qYJg</id>
    <link href="https://mp.weixin.qq.com/s/-PRfwy2IVg4NfnCtJ-qYJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>权威学术期刊主编如何看待新冠疫苗？</title>
    <updated>2020-12-22T12:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/SgV7-QqaVohUe932Ul8lUQ</id>
    <link href="https://mp.weixin.qq.com/s/SgV7-QqaVohUe932Ul8lUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷发布 | 规范疫苗批签发管理， 《生物制品批签发管理办法》2021年3月1日起实施</title>
    <updated>2020-12-22T12:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/EuDO0cI2cveZWAgg5jueEA</id>
    <link href="https://mp.weixin.qq.com/s/EuDO0cI2cveZWAgg5jueEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物工艺江湖的生存之道：固守还是破局？</title>
    <updated>2020-12-21T13:06:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/caBAzRg4POz6dsM-k8XOoA</id>
    <link href="https://mp.weixin.qq.com/s/caBAzRg4POz6dsM-k8XOoA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK布局IBD新疗法，成功入选Sosei的global licensing名单</title>
    <updated>2020-12-21T13:06:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/qavo3EGaX56blMTmkLaL2g</id>
    <link href="https://mp.weixin.qq.com/s/qavo3EGaX56blMTmkLaL2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>降低复发风险80%！谁说EGFR治疗NSCLC的TMB不高？FDA批准阿斯利康辅助疗法</title>
    <updated>2020-12-21T13:06:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/7k9GIF-G40xknDX7X-lXKA</id>
    <link href="https://mp.weixin.qq.com/s/7k9GIF-G40xknDX7X-lXKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>使用先进的生物工艺数据管理平台提升R&amp;D阶段的质量和效率！</title>
    <updated>2020-12-21T13:06:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/Mx8nO39kK8_jVOuyfZG2MQ</id>
    <link href="https://mp.weixin.qq.com/s/Mx8nO39kK8_jVOuyfZG2MQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯40|纵览全球药物靶点动态</title>
    <updated>2020-12-20T12:12:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/r84AU8PQiUqt5hg_0iO47g</id>
    <link href="https://mp.weixin.qq.com/s/r84AU8PQiUqt5hg_0iO47g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 Think Big 十佳入选项目专访 | 朔望医药：用基因治疗守护人类视觉健康</title>
    <updated>2020-12-19T10:19:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/GneIqva9_VBjsx3uUyoBig</id>
    <link href="https://mp.weixin.qq.com/s/GneIqva9_VBjsx3uUyoBig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA毫无悬念批准第二款新冠疫苗，定价最低25美元</title>
    <updated>2020-12-19T10:19:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/Pz--d0OH23O_NDMGXeDdaQ</id>
    <link href="https://mp.weixin.qq.com/s/Pz--d0OH23O_NDMGXeDdaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>葛兰素史克（GSK）8亿美元押注全新免疫检查点PVRIG</title>
    <updated>2020-12-18T12:55:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/beiGw0jC-3vt3cAKA0R61Q</id>
    <link href="https://mp.weixin.qq.com/s/beiGw0jC-3vt3cAKA0R61Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>除了Margenza，还有哪些HER2乳腺癌辅助治疗方案？</title>
    <updated>2020-12-18T12:55:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/MSOxVb4ERzqCAboUDVPj0w</id>
    <link href="https://mp.weixin.qq.com/s/MSOxVb4ERzqCAboUDVPj0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年底跳槽季，什么岗位能洞悉生物医药行业局势？</title>
    <updated>2020-12-18T12:55:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/_HiuYRD54dbU6mbJyy-4Kw</id>
    <link href="https://mp.weixin.qq.com/s/_HiuYRD54dbU6mbJyy-4Kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷分享 | CDE官方指导文件获取！</title>
    <updated>2020-12-18T12:55:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/BX12Hh2mSy15DFQoMdyMNQ</id>
    <link href="https://mp.weixin.qq.com/s/BX12Hh2mSy15DFQoMdyMNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关于新冠疫苗，我们应该期待什么？</title>
    <updated>2020-12-17T12:29:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/udg4YlbINYgd8gN59LkGRA</id>
    <link href="https://mp.weixin.qq.com/s/udg4YlbINYgd8gN59LkGRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>非小细胞肺癌靶向新药--KRAS G12C抑制剂</title>
    <updated>2020-12-17T12:29:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/wVGRRnPdAbSShZEXrGNjpA</id>
    <link href="https://mp.weixin.qq.com/s/wVGRRnPdAbSShZEXrGNjpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷发布 | 股价大涨9%，再破5000亿！恒瑞PD-1四个适应症全进医保！</title>
    <updated>2020-12-17T12:29:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/_UKIvZ__FOpppcAdEV1a2w</id>
    <link href="https://mp.weixin.qq.com/s/_UKIvZ__FOpppcAdEV1a2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>